These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29538754)

  • 1. The patient experience of Raynaud's phenomenon in systemic sclerosis.
    Pauling JD; Saketkoo LA; Matucci-Cerinic M; Ingegnoli F; Khanna D
    Rheumatology (Oxford); 2019 Jan; 58(1):18-26. PubMed ID: 29538754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis.
    Pauling JD; Domsic RT; Saketkoo LA; Almeida C; Withey J; Jay H; Frech TM; Ingegnoli F; Dures E; Robson J; McHugh NJ; Herrick AL; Matucci-Cerinic M; Khanna D; Hewlett S
    Arthritis Care Res (Hoboken); 2018 Sep; 70(9):1373-1384. PubMed ID: 29473715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving Symptom Characteristics of Raynaud's Phenomenon in Systemic Sclerosis and Their Association With Physician and Patient-Reported Assessments of Disease Severity.
    Pauling JD; Reilly E; Smith T; Frech TM
    Arthritis Care Res (Hoboken); 2019 Aug; 71(8):1119-1126. PubMed ID: 30133174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raynaud's phenomenon-an update on diagnosis, classification and management.
    Pauling JD; Hughes M; Pope JE
    Clin Rheumatol; 2019 Dec; 38(12):3317-3330. PubMed ID: 31420815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud's Phenomenon (ASRAP) questionnaire.
    Pauling JD; Yu L; Frech TM; Herrick AL; Hummers LK; Shah AA; Denton CP; Saketkoo LA; Withey J; Khanna D; Domsic RT
    Rheumatology (Oxford); 2024 May; 63(5):1281-1290. PubMed ID: 37481713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Influencing Patient Decision-Making Concerning Treatment Escalation in Raynaud's Phenomenon Secondary to Systemic Sclerosis.
    Hughes M; Huang S; Pauling JD; Sabbagh M; Khanna D
    Arthritis Care Res (Hoboken); 2021 Dec; 73(12):1845-1852. PubMed ID: 34057304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical relevance of Raynaud's phenomenon symptom characteristics in systemic sclerosis.
    Hughes M; Huang S; Pauling JD; Sabbagh M; Khanna D
    Clin Rheumatol; 2022 Oct; 41(10):3049-3054. PubMed ID: 35583625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raynaud's phenomenon.
    Herrick AL; Wigley FM
    Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101474. PubMed ID: 32007400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group.
    Chapman LS; Alcacer-Pitarch B; Pauling JD; Flurey CA; Redmond AC; Richards P; Herrick AL; Merkel PA; Proudman S; Menz HB; Helliwell PS; Hannan MT; Domsic RT; Saketkoo LA; Shea B; Siddle HJ
    Semin Arthritis Rheum; 2024 Apr; 65():152372. PubMed ID: 38325052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
    Fontenelle SM; Kayser C; Pucinelli ML; Andrade LE
    Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group Report.
    Pauling JD; Frech TM; Hughes M; Gordon JK; Domsic RT; Anderson ME; Ingegnoli F; McHugh NJ; Johnson SR; Hudson M; Boin F; Ong VH; Matucci-Cerinic M; Altorok N; Scolnik M; Nikpour M; Shah A; Pope JE; Khanna D; Herrick AL
    J Scleroderma Relat Disord; 2018 Oct; 3(3):249-252. PubMed ID: 30705970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's phenomenon.
    Hughes M; Herrick AL
    Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):112-32. PubMed ID: 27421220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
    Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domain reporting in systemic sclerosis-related Raynaud's phenomenon: An OMERACT scoping review.
    Maltez N; Hughes M; Brown E; Hickey V; Shea B; Herrick AL; Proudman S; Merkel PA; Pauling JD
    Semin Arthritis Rheum; 2023 Aug; 61():152208. PubMed ID: 37202251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raynaud's phenomenon and vascular disease in systemic sclerosis.
    Generini S; Matucci Cerinic M
    Adv Exp Med Biol; 1999; 455():93-100. PubMed ID: 10599328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing a core set of outcome measure domains to study Raynaud's phenomenon and digital ulcers in systemic sclerosis: Report from OMERACT 2020.
    Maltez N; Hughes M; Brown E; Hickey V; Park H; Shea B; Herrick AL; Pauling JD; Proudman S; Merkel PA
    Semin Arthritis Rheum; 2021 Jun; 51(3):640-643. PubMed ID: 33947582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choroidal impairment and macular thinning in patients with systemic sclerosis: the acute study.
    Ingegnoli F; Gualtierotti R; Pierro L; Del Turco C; Miserocchi E; Schioppo T; Meroni PL; ;
    Microvasc Res; 2015 Jan; 97():31-6. PubMed ID: 25262916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of laser-derived imaging for assessing digital perfusion in clinical trials of systemic sclerosis-related digital vasculopathy: A systematic literature review.
    Pauling JD; Hackett N; Guida A; Merkel PA
    Semin Arthritis Rheum; 2020 Oct; 50(5):1114-1130. PubMed ID: 32920325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.